Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) in Patients with Calr-Mutated Myelofibrosis

被引：0

作者：

Boluda, Juan Carlos Hernandez ^{[1
]}

Eikema, Dirk-Jan ^{[2
]}

Erazo, Nadia ^{[3
]}

Kroeger, Nicolaus ^{[4
]}

Robin, Marie ^{[5
]}

de Witte, Moniek ^{[6
]}

Finke, Juergen ^{[7
]}

Rambaldi, Alessandro ^{[8
]}

Broers, Annoek E. C. ^{[9
]}

Raida, Ludek ^{[10
,11
]}

Schaap, Nicolaas ^{[12
]}

Chiusolo, Patrizia ^{[13
]}

Verbeek, Mareike ^{[14
]}

Choi, Goda ^{[15
]}

Halaburda, Kazimierz ^{[16
]}

Kulagin, Alexander D. ^{[17
]}

Labussiere-Wallet, Helene ^{[18
]}

Gedde-Dahl, Tobias ^{[19
]}

Rabitsch, Werner ^{[20
]}

Raj, Kavita ^{[21
]}

Drozd-Sokolowska, Joanna ^{[22
]}

Polverelli, Nicola ^{[23
]}

Czerw, Tomasz ^{[24
,25
]}

Yakoub-Agha, Ibrahim ^{[26
]}

McLornan, Donal P. ^{[27
]}

机构：

[1] Hosp Clin Univ, Hematol Dept, Valencia, Spain

[2] EBMT Stat Unit, Leiden, Netherlands

[3] EBMT Leiden Study Unit, Leiden, Netherlands

[4] Univ Med Ctr Hamburg Eppendorf, Dept Stem Cell Transplantat, Hamburg, Germany

[5] Univ Paris Cite, Hop St Louis, AP HP, Paris, France

[6] UMC Utrecht, Utrecht, Netherlands

[7] Univ Freiburg, Fac Med, Dept Hematol Oncol & Stem Cell Transplantat, Freiburg, Germany

[8] Azienda Socio Sanit Terr Papa Giovanni XXIII, Dept Oncol Hematol, Bergamo, Italy

[9] Erasmus MC Canc Inst, Dept Hematol, Rotterdam, Netherlands

[10] Palacky Univ Olomouc, Fac Med & Dent, Dept Hematooncol, Olomouc, Czech Republic

[11] Univ Hosp Olomouc, Olomouc, Czech Republic

[12] Radboud Univ Nijmegen, Dept Hematol, Med Ctr, Nijmegen, Netherlands

[13] Fdn Policlin Univ A Gemelli IRCCS, Dept Diagnost Immagini Radioterapia Oncol & Emato, Rome, Italy

[14] TUM, Klinikum Rechts Isar, Munich, Germany

[15] Univ Groningen, Univ Med Ctr Groningen, Dept Hematol, Groningen, Netherlands

[16] Inst Hematol & Transfus Med, Warsaw, Poland

[17] Pavlov Univ, RM Gorbacheva Res Inst, St Petersburg, Russia

[18] Ctr Hosp Lyon Sud, Hematol Dept 1 G, Pierre Benite, France

[19] Oslo Univ Hosp, Rikshosp, Hematol Dept, Clin Canc Med,Sect Stem Cell Transplantat, Oslo, Norway

[20] Med Univ Vienna, BMT Unit, Vienna Gen Hosp, Internal Med 1, Vienna, Austria

[21] Univ Coll London Hosp NHS Trust, London, England

[22] Med Univ Warsaw, Cent Clin Hosp, Warsaw, Poland

[23] Univ Brescia, Dept Clin & Expt Sci, Unit Blood Dis & Stem Cell Transplantat, ASST Spedali Civili Brescia, Brescia, Italy

[24] Maria Sklodowska Curie Mem Canc Ctr, Gliwice, Poland

[25] Inst Oncol, Gliwice Branch, Gliwice, Poland

[26] Univ Lille, INSERM, U1286, Ctr Hosp Univ Lille LIRIC, Lille, France

[27] Univ Coll London Hosp, Dept Haematol & Stem Cell Transplantat, London, England

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-163048

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：10608 / 10610

页数：3

共 50 条

[1] Early Hepatotoxicity in Patients with Myelofibrosis after Allogeneic Hematopoietic Cell Transplantation (Allo-HCT)
Robin, Marie
Gras, Luuk
Gagelmann, Nico
Koster, Linda
de Latour, Regis Peffault
Van Gorkom, Gwendolyn
Ganser, Arnold
Itala-Remes, Maija
Zuckerman, Tsila
Beguin, Yves
Schaap, Nicolaas
Drozd-Sokolowska, Joanna
Raj, Kavita
Hayden, Patrick J.
de Wreede, Liesbeth C.
Czerw, Tomasz
Hernandez Boluda, Juan Carlos
Kroeger, Nicolaus
Yakoub-agha, Ibrahim
McLornan, Donal P.
BLOOD, 2022, 140 : 7585 - 7586
[2] Allogeneic hematopoietic cell transplantation in patients with CALR-mutated myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT
Hernandez-Boluda, Juan Carlos
Eikema, Diderik-Jan
Koster, Linda
Kroeger, Nicolaus
Robin, Marie
de Witte, Moniek
Finke, Juergen
Finazzi, Maria Chiara
Broers, Annoek
Raida, Ludek
Schaap, Nicolaas
Chiusolo, Patrizia
Verbeek, Mareike
Hazenberg, Carin L. E.
Halaburda, Kazimierz
Kulagin, Aleksandr
Labussiere-Wallet, Helene
Gedde-Dahl, Tobias
Rabitsch, Werner
Raj, Kavita
Drozd-Sokolowska, Joanna
Battipaglia, Giorgia
Polverelli, Nicola
Czerw, Tomasz
Yakoub-Agha, Ibrahim
Mclornan, Donal P.
BONE MARROW TRANSPLANTATION, 2023, 58 (12) : 1357 - 1367
[3] Allogeneic hematopoietic cell transplantation in patients with CALR-mutated myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT
Juan Carlos Hernández-Boluda
Diderik-Jan Eikema
Linda Koster
Nicolaus Kröger
Marie Robin
Moniek de Witte
Jürgen Finke
Maria Chiara Finazzi
Annoek Broers
Ludek Raida
Nicolaas Schaap
Patrizia Chiusolo
Mareike Verbeek
Carin L. E. Hazenberg
Kazimierz Halaburda
Aleksandr Kulagin
Hélène Labussière-Wallet
Tobias Gedde-Dahl
Werner Rabitsch
Kavita Raj
Joanna Drozd-Sokolowska
Giorgia Battipaglia
Nicola Polverelli
Tomasz Czerw
Ibrahim Yakoub-Agha
Donal P. McLornan
Bone Marrow Transplantation, 2023, 58 : 1357 - 1367
[4] ABO incompatibility has no effect on the outcome of allogeneic hematopoietic cell transplantation (allo-HCT)
Sakellari, I
Stavroylanni, N
Kalogiannidis, P
Marantidou, M
Ganidou, M
Natse, T
Batsis, I
Anagnostopoulos, A
Fassas, A
BONE MARROW TRANSPLANTATION, 2002, 29 : S115 - S115
[5] Effectiveness of allogeneic hematopoietic stem cell transplantation (allo-HCT) in patients transplanted with active myeloid disease
Liga, Maria
Spyridis, Nikolaos
Triantafyllou, Evi
Marangos, Markos
Spyridonidis, Alexandros
BONE MARROW TRANSPLANTATION, 2018, 53 : 495 - 496
[6] Allogeneic hematopoietic cell transplantation (allo-HCT) for acute myeloid leukemia - prognostic factors and outcome
Sakellari, I
Fassas, A
Yannaki, E
Saloum, R
Lalayanni, C
Batsis, I
Stamatopoulos, K
Eglezou, E
Kontodimou, A
Anagnostopoulos, A
BONE MARROW TRANSPLANTATION, 2003, 31 : S177 - S177
[7] NEUROLOGICAL COMPLICATIONS IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT (ALLO-HCT) RECIPIENTS
Crespo Ana, Puchol
Bastida Carlota, Mayor
Lopez Sofia, Diaz
Alvarez Angela, Figuera
Bueno Beatriz, Aguado
HAEMATOLOGICA, 2021, 106 (10) : 275 - 275
[8] Antibody response to SARS-CoV-2 vaccination in patients following allogeneic hematopoietic cell transplantation (allo-HCT)
Huang, A.
Cicin-Sain, C.
Pasin, C.
Mueller, N. J.
Nilsson, J.
Vilinovszki, O.
Nair, G.
Wolfensberger, N.
Hockl, P.
Schanz, U.
Trkola, A.
Kouyos, R.
Hasse, B.
Zinkernagel, A.
Manz, M. G.
Abela, I. A.
Muller, A. M. S.
ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 64 - 65
[9] Toxicities in older adult patients undergoing CD34+selected allogeneic hematopoietic stem cell transplantation (allo-HCT)
Shah, G. L.
Scordo, M.
Kosuri, S.
Herrera, D. Adrianzen
Maloy, M.
Nieves, J. L.
Devlin, S.
Avecilla, S. T.
Meagher, R.
Shaffer, B.
Perales, M. -A.
Gyurkocza, B.
Castro-Malaspina, H.
Giralt, S. A.
Tamari, R.
BONE MARROW TRANSPLANTATION, 2016, 51 : S226 - S227
[10] Cardiac risks of imatinib in chronic myelogenous leukemia (CML) patients who receive allogeneic hematopoietic cell transplantation (Allo-HCT)
Burke, M. J.
Gursahaney, A.
Trotz, B.
Luo, X.
Baker, K. S.
Weisdorf, D. J.
Wagner, J. E.
Michael, V. R.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)

← 1 2 3 4 5 →